
Researchers at Hyderabad’s Centre for Cellular and Molecular Biology (CCMB) have identified two genes, NR2F1 and NR2F6, that enable severed nerve fibres to regrow after spinal cord injury in mice, restoring partial movement. The genes were found to decline by 70 to 80 per cent in adult brains, and reactivating either one prompted fibres to cross the injury site and extend up to 1.5 mm beyond it.

Led by Dr Ishwariya Venkatesh, with first author Yogesh Sahu, the study published in The EMBO Journal showed treated mice lifted their hind limbs, improved grip strength, and pushed backwards from five weeks after injury, while untreated mice showed no regrowth. The two genes work through opposite mechanisms: NR2F1 activates growth genes, while NR2F6 represses routine cell functions to redirect resources toward repair.
The work remains preclinical, as genes were delivered before injury and recovery was partial. The findings provide a framework for developing future gene therapies for spinal cord repair.
All three outlets, Deccan Herald, Telangana Today and The Hindu, present the CCMB study as straight news, attributing the key findings to the researchers and noting the preclinical limitations. None adopts a government-critical or pro-government stance, and no outlet omits the important caveat that genes were delivered before injury and recovery was partial. The uniform framing reflects a consensus that the discovery is scientifically significant but early-stage. The concrete next step named across sources is the need for further preclinical work before any human gene therapy can be designed.
Coverage: 3 sources, 3 neutral
Sources (3): deccanherald.com (neutral report), telanganatoday.com (neutral report), thehindu.com (neutral report)
This brief was synthesised by AI from the 3 sources linked above, so one read covers every framing they carry. Methodology and corrections.